Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Body composition in multiple sclerosis.
Evaluation of changes in retinal nerve fiber layer thickness and visual functions in cases of optic neuritis and multiple sclerosis.
Outcome Measures for Individuals With Multiple Sclerosis: Recommendations From the American Physical Therapy Association Neurology Section Task Force.
Multiple Sclerosis Alters the Mechanical Work Performed on the Body's Center of Mass during Gait.
Afferent visual pathways in multiple sclerosis: a review.
Suicide risk in multiple sclerosis: A systematic review of current literature.
Meningeal and Choroid Plexus Cells - Novel Drug Targets for CNS Disorders.
Aquaporin-4 antibody-negative neuromyelitis optica: Distinct assay sensitivity-dependent entity.
iPINBPA: AN INTEGRATIVE NETWORK-BASED FUNCTIONAL MODULE DISCOVERY TOOL FOR GENOME-WIDE ASSOCIATION STUDIES.
Statin Treatment in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Multiple sclerosis presenting initially with a worsening of migraine symptoms.
Reduced sick leave in multiple sclerosis after one year of natalizumab treatment. A prospective ad hoc analysis of the TYNERGY trial.
Reconstruction of the human cerebral cortex robust to white matter lesions: Method and validation.
Switch-associated protein 70 antibodies in multiple sclerosis: relationship between increased serum levels and clinical relapse.
Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain.
Interaction between HLA-DRB1-DQB1 Haplotypes in Sardinian Multiple Sclerosis Population.
Efficient transdifferentiation of human adipose-derived stem cells into Schwann-like cells: A promise for treatment of demyelinating diseases.
Postinfectious neurologic syndromes: A prospective cohort study.
Longitudinal JCV serology in multiple sclerosis patients preceding natalizumab-associated progressive multifocal leukoencephalopathy.
Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study.
Immune-mediated disorders among women carriers of fragile X premutation alleles.
[Amino acids content in the blood serum of patients with multiple sclerosis.]
The spectrum of post-vaccination inflammatory CNS demyelinating syndromes.
Simple MRI Metrics Contribute to Optimal Care of the Patient with Multiple Sclerosis.
Complex assessment in progressive multiple sclerosis: a case report.
Pages
« first
‹ previous
…
277
278
279
280
281
282
283
284
285
…
next ›
last »